PXD014277 is an
original dataset announced via ProteomeXchange.
Dataset Summary
Title | Proteomics of blood sera from Macaca fascicularis in the framework of the development of a vaccine against Lassa virus. |
Description | Next-generation proteomics of blood sera from Macaca fascicularis monkeys immunized with measles-based and Mopeia-based vaccine platforms. |
HostingRepository | PRIDE |
AnnounceDate | 2020-02-25 |
AnnouncementXML | Submission_2020-02-25_08:55:17.xml |
DigitalObjectIdentifier | https://dx.doi.org/10.6019/PXD014277 |
ReviewLevel | Peer-reviewed dataset |
DatasetOrigin | Original dataset |
RepositorySupport | Supported dataset by repository |
PrimarySubmitter | Jean ARMENGAUD |
SpeciesList | scientific name: Macaca fascicularis; NCBI TaxID: 9541; |
ModificationList | Deamidated; Oxidation; Carbamidomethyl |
Instrument | Q Exactive |
Dataset History
Revision | Datetime | Status | ChangeLog Entry |
0 | 2019-06-17 09:09:46 | ID requested | |
⏵ 1 | 2020-02-25 08:55:19 | announced | |
Publication List
Keyword List
submitter keyword: serum, virus, vaccine, immunization, blood serum, shotgun proteomics, primate |
Contact List
Jean Armengaud |
contact affiliation | CEA-Marcoule, ProGénoMIX platform, DRF-Li2D, 30207 Bagnols-sur-Cèze, France |
contact email | jean.armengaud@cea.fr |
lab head | |
Jean ARMENGAUD |
contact affiliation | Li2D |
contact email | jean.armengaud@cea.fr |
dataset submitter | |
Full Dataset Link List
Dataset FTP location
NOTE: Most web browsers have now discontinued native support for FTP access within the browser window. But you can usually install another FTP app (we recommend FileZilla) and configure your browser to launch the external application when you click on this FTP link. Or otherwise, launch an app that supports FTP (like FileZilla) and use this address: ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2020/02/PXD014277 |
PRIDE project URI |
Repository Record List
[ + ]
[ - ]
- PRIDE
- PXD014277
- Label: PRIDE project
- Name: Proteomics of blood sera from Macaca fascicularis in the framework of the development of a vaccine against Lassa virus.